PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast
By PVI, PeerView Institute for Medical Education
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 82
Reviews: 0
Episodes: 54
Description
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
| Episode | Date |
|---|---|
|
James E. Galvin, MD, MPH - Navigating Advances in Alzheimer’s Disease: An Expert Consult on Integrating the New Diagnostic Tools and Disease-Modifying Therapies Into Your Clinical Practice
|
Apr 10, 2024 |
|
Jerome A. Barakos, MD / Tammie L.S. Benzinger, MD, PhD - Improving the Recognition and Management of Amyloid-Related Imaging Abnormalities (ARIA) in Alzheimer’s Disease Treatment: Practical Tools and Strategies for Radiology and Neuroradiology Specialists
|
Mar 11, 2024 |
|
Manmeet S. Ahluwalia, MD, MBA, FASCO - Brainstorming New Approaches to Improve Glioblastoma Care: Revolutionary Advances With Modern Gene Fusion–Targeted Therapy
|
Jan 12, 2024 |
|
James F. Howard Jr., MD - FcRn Modulation as a Targeted Approach to Myasthenia Gravis Management: From Pathophysiologic Rationale to Practical Application
|
Dec 01, 2023 |
|
Claudia A. Chiriboga, MD, MPH, FAAN - Building a Better Bridge: Providing Continuous SMA Care From Adolescence Through Adulthood
|
Nov 24, 2023 |
|
Alan K. Percy, MD - From Early Recognition to Age- and Stage-Appropriate Care: Navigating a New Era in Rett Syndrome Management
|
Nov 24, 2023 |
|
Eric Marsh, MD, PhD - Honing Diagnostic and Management Skills: The Role of the Pediatrician in the New Era of Rett Syndrome Management
|
Nov 24, 2023 |
|
James D. Berry, MD, MPH - Making the Most of Advances in Amyotrophic Lateral Sclerosis: Strategies to Improve Early Diagnosis and Maximize the Benefit of Novel Treatment Options
|
Nov 24, 2023 |
|
Josh Hamilton, DNP, RN/PMH-BC, FNP-C, PMHNP-BC, CTMH, CNE, CLNC, FAANP / Rhone D'Errico, DNP, MBA, APRN, FNP-BC, PMHNP-BC, ENP-C, CNE, ACUE - Realizing the Potential of Rapid-Acting Treatments for Depression: Key Clinical Evidence, Practical Considerations, and Best Practices for Individualized, Patient-Centered Care
|
Oct 31, 2023 |
|
Jeffrey L. Neul, MD, PhD - The Changing Future for Patients With Rett Syndrome and Their Families: Early Diagnosis and New and Emerging Therapies to Reduce the Burdens of Disease
|
Oct 19, 2023 |
|
Michael Levy, MD, PhD - Test Your Knowledge: Are You Missing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease (MOGAD)?
|
Aug 29, 2023 |
|
Stephen P. Salloway, MD, MS - Case by Case: Actioning Patient-Centered Strategies for Risk Assessment, Diagnosis, and Management of Amyloid-Related Imaging Abnormalities (ARIA)
|
Aug 24, 2023 |
|
Philip Harvey, PhD - Visualizing a New Horizon: Emerging Advances in the Treatment of Cognitive Impairment Associated With Schizophrenia
|
Aug 07, 2023 |
|
Ilya M. Nasrallah, MD, PhD - Navigating the New Era of Molecularly Defined Care in Alzheimer’s Disease: Applying Nuclear Medicine to Quantify Neuropathology and Improve Diagnostic Accuracy in the Earliest Stages of the AD Continuum
|
Jul 28, 2023 |
|
Jiwon Oh, MD, PhD, FRCPC - New and Emerging Biomarkers in Patient-Centered MS Management: The Future of Personalized Patient Care Begins Now
|
Jul 05, 2023 |
|
Amit Bar-Or, MD, FRCPC - Can a Novel DMT Class Deliver Better Outcomes in MS? Considering the Potential of BTK Inhibition
|
Jul 05, 2023 |
|
Jessica Ailani, MD, FAHS, FAAN, FANA - Breakthrough Therapies for the Prevention and Acute Treatment of Migraine: Addressing Unmet Needs in the Primary Care Setting
|
Jun 27, 2023 |
|
Vera Bril, BSc, FRCPC, MD - Leveraging FcRn Modulation in Personalized Management of Generalized Myasthenia Gravis: Applying the Evidence, Tools, and Patient Perspectives to Achieve Treatment Goals
|
Jun 01, 2023 |
|
Daniel S. Reich, MD, PhD - Targeting BTK: The Latest Data on the Evolving Treatment Landscape for Patients With MS
|
Jun 01, 2023 |
|
Anna Chodos, MD, MPH - Facilitating Cognitive Assessment in Primary Care for the Timely Detection of Alzheimer’s Disease: Leveraging Medicare Reimbursement Mechanisms to Improve Clinical Care
|
Jun 01, 2023 |
|
Robert C. Green, MD, MPH - Revisiting the Role of Genetic Testing in Patients at Risk for Late-Onset Alzheimer’s Disease: How Will the Latest Evidence and Evolving Management Paradigm Impact Treatment Decisions for Your Patients?
|
Apr 06, 2023 |
|
John Ravits, MD, FAAN - Hope Is on the Horizon for Patients With ALS: Overcoming Diagnostic Difficulties and Exploring Novel Emerging Therapeutic Approaches
|
Apr 06, 2023 |
|
Benjamin M. Greenberg, MD, MHS / Jiwon Oh, MD, PhD, FRCPC - BTK Inhibition as an MS Treatment Modality: Where Do We Stand and Where Are We Headed?
|
Mar 28, 2023 |
|
Marwan Sabbagh, MD, FAAN - Gearing Up for Plasma Biomarkers in the Clinic: Real-World Strategies to Facilitate the Timely and Accurate Neuropathological Diagnosis of Alzheimer’s Disease
|
Mar 01, 2023 |
|
Val J. Lowe, MD - Revealing the Neuropathology of Alzheimer’s Disease Through Novel Fluid and Imaging Biomarkers: Ushering in a Precision Era of Diagnosis and Treatment
|
Jan 12, 2023 |
|
James F. Howard Jr., MD - Identifying Myasthenia Gravis and Assessing Patients’ Response to Treatment to Improve Outcomes
|
Jan 12, 2023 |
|
David G. Warnock, MD - The Future Looks Bright for People With Fabry Disease: Improving Diagnosis and Expanding Treatment Options
|
Dec 19, 2022 |
|
Jiwon Oh, MD, PhD, FRCPC - Moving Toward the Future in MS Management: What's the Latest on BTK Inhibition?
|
Nov 22, 2022 |
|
Richard K. Bogan, MD, FCCP, FAASM - Managing Disorders of Hypersomnolence: Reducing Patient Burdens, Protecting Patient Health
|
Nov 14, 2022 |
|
James F. Howard Jr., MD - A Targeted Approach to Management of Generalized Myasthenia Gravis: The Latest on Novel Therapies That Improve Patient Outcomes
|
Nov 03, 2022 |
|
Jeffrey L. Neul, MD, PhD - Encouraging News in Rett Syndrome: Steps Towards a Timely, Accurate Diagnosis and Treatment Breakthroughs
|
Sep 22, 2022 |
|
Alexander Drilon, MD - Uncovering Gene Fusions and Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
|
Aug 25, 2022 |
|
David Cornblath, MD - Optimizing Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy: Honing Diagnostic Accuracy, Personalizing Treatment Plans
|
Aug 10, 2022 |
|
Bruce Cree, MD, PhD, MAS - Re-Examining S1PR Modulation From All Angles in Relapsing Multiple Sclerosis: Impact on Physical and Cognitive Outcomes, and Practical Considerations of Long-Term Therapy
|
Aug 05, 2022 |
|
Benjamin M. Greenberg, MD, MHS / Professor Anthony Traboulsee, MD - Innovations and Imaging in Multiple Sclerosis: Examining the Evidence, Looking Toward the Future of Bruton Tyrosine Kinase Inhibitors
|
Jul 19, 2022 |
|
David Weidman, MD - Therapeutic Advances in the Early Treatment of Alzheimer’s Disease: Expert Insights on Novel Biomarkers and Emerging Disease-Modifying Therapies
|
Jul 11, 2022 |
|
Liana G. Apostolova, MS, MD, FAAN - Accelerating Progress in the Treatment of Alzheimer’s Disease: How Can We Achieve Timely and Accurate Neuropathological Diagnosis and Precision Management of Mild Cognitive Impairment in Early Alzheimer’s Disease?
|
May 27, 2022 |
|
Bruce Cree, MD, PhD, MAS - Leveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis Care
|
May 27, 2022 |
|
Joe R. Anderson, PharmD, PhC - Taking the Pulse of Undiagnosed Atrial Fibrillation: Pharmacists as a Lynchpin of Detection and Team-Based Care
|
May 23, 2022 |
|
Anita H. Clayton, MD - Recent Advances in the Management of Depressive Disorders: Preparing for a Shift in the Treatment Paradigm
|
Apr 29, 2022 |
|
Kristina M. Deligiannidis, MD - Applying Evidence to Practice in Postpartum Depression: Expert Guidance on Integrating Therapeutic Innovations and Shared Decision-Making Strategies to Optimize Patient Care
|
Apr 29, 2022 |
|
Julie Parsons, MD - Breakthroughs in Spinal Muscular Atrophy: Managing the Life-Changing Impact of Gene Replacement Therapy
|
Apr 15, 2022 |
|
Gregory W. Albers, MD / S. Claiborne “Clay” Johnston, MD, PhD - Mastering the Use of Dual Antiplatelet Therapy for Preventing Recurrent Stroke: How Well Do Your Current Strategies Match With the Experts?
|
Apr 15, 2022 |
|
Amit Bar-Or, MD, FRCPC / Daniel S. Reich, MD, PhD - Rationale, Evidence, and Practical Potential for BTK Inhibitors in Patient-Centered MS Care: Where We Stand Now
|
Apr 04, 2022 |
|
"Mark S. Freedman, MD - Leveraging S1PR Modulators to Provide Patient-Centered MS Care: An Expert-Driven Review of the Data"
|
Mar 29, 2022 |
|
Tammie L.S. Benzinger - The Expanding Role of Neuroimaging in Alzheimer’s Disease Diagnosis and Management: Is Radiology Prepared for New Challenges?
|
Mar 01, 2022 |
|
Alan "Tony" Amberg - Addressing Unmet Needs in the Management of Schizophrenia and Bipolar Disorder: New and Emerging Therapeutic Options to Enhance Treatment and Maximize Patient Outcomes
|
Feb 23, 2022 |
|
Anita H. Clayton, MD - Recent Advances and Novel Options in Depression: Reviewing the Evidence for GABA-Modulating Neuroactive Steroids for Major Depressive Disorder
|
Feb 15, 2022 |
|
Steven Brem, MD - A New Wave of Progress in Glioblastoma: Expert Guidance on Delivering Modern Personalized Care With Tumor Treating Fields and Novel Systemic Approaches
|
Jan 26, 2022 |
|
Lenard A. Adler, MD / Oren Mason, MD - Overcoming Challenges in the Recognition and Management of Adult ADHD in Primary Care: Optimizing Outcomes to Reduce Disease Burden and Improve Quality of Life
|
Jan 11, 2022 |
|
Benjamin M. Greenberg, MD, MHS & Professor Anthony Traboulsee, MD - Bruton Tyrosine Kinase Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach
|
Dec 08, 2021 |
|
Erik P. Sulman, MD, PhD - Implementing Synergistic Multimodal Approaches With Tumor Treating Fields to Extend Survival in Aggressive Cancers
|
Dec 08, 2021 |
|
Bruce Cree, MD, PhD, MAS - Exploring the Convergence of Advances in S1P Receptor Modulation With Progress in Understanding Brain Atrophy and Cognition Measures in Multiple Sclerosis
|
Nov 22, 2021 |
|
Professor Dame Pamela J. Shaw - On the Cusp of a New Targeted Treatment Era in ALS: Exploring the Emerging Therapeutic Landscape
|
Nov 03, 2021 |